Targeted immunotherapy with sphingosine-1-phosphate improves myocardial contractility and mitochondrial function in a novel murine ex vivo perfusion and transplantation model.
Iguidbashian J, Zakrzewski J, Lu L, Garcia AM, Khailova L, Deng X, Plenter R, La Rosa FG, Nakano S, Lynch K, Jaggers J, Davidson J, Stone ML. Targeted immunotherapy with sphingosine-1-phosphate improves myocardial contractility and mitochondrial function in a novel murine ex vivo perfusion and transplantation model. J Thorac Cardiovasc Surg. 2025 09; 170(3):764-771.